Bluejay Diagnostics, Inc.
BJDX
$4.00
-$0.03-0.74%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 40.13% | -6.31% | -1.12% | -0.20% | 18.32% |
| Total Depreciation and Amortization | -0.19% | -1.10% | -3.55% | -79.21% | -7.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.45% | 5,049.18% | 185.31% | 66.35% | -244.07% |
| Change in Net Operating Assets | -1,056.24% | -76.25% | 93.40% | -154.71% | -6.72% |
| Cash from Operations | -4.20% | 19.27% | 17.33% | -146.87% | 23.86% |
| Capital Expenditure | 99.93% | -662.71% | 59.73% | -17.99% | 62.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.93% | -662.71% | 59.73% | -17.99% | 62.95% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 80.59% | -39,791.67% | -300.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -99.99% | 144.83% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -59.41% | -39,400.00% | 99.56% | -- |
| Cash from Financing | -104.93% | 170.13% | 89,912.90% | -100.26% | 43,659.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.66% | 1,092.22% | 115.78% | -12,105.96% | 98.60% |
